Dong Mei Su
Direktor/Vorstandsmitglied bei 3SBIO INC.
Vermögen: 20 Mio $ am 30.04.2024
Aktive Positionen von Dong Mei Su
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| 3SBIO INC. | Direktor/Vorstandsmitglied | 11.06.2012 | - |
| Corporate Officer/Principal | 27.11.2014 | - | |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Direktor/Vorstandsmitglied | 09.09.2022 | - |
| Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. | Direktor/Vorstandsmitglied | 01.11.2006 | - |
| Liaoning Sunshine Science & Technology Development Co. Ltd. | Direktor/Vorstandsmitglied | 01.09.2009 | - |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Direktor/Vorstandsmitglied | 01.01.1993 | - |
| Corporate Officer/Principal | 01.01.1993 | - | |
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
 Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Direktor/Vorstandsmitglied | 16.11.2018 | - |
Strategic International Group Ltd.
 Strategic International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Dong Mei Su
Ehemalige bekannte Positionen von Dong Mei Su
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Hongkong Sansheng Medical Ltd.
 Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Direktor/Vorstandsmitglied | 01.11.2009 | 01.11.2014 |
Guangdong Sunshine Pharmaceutical Co., Ltd.
 Guangdong Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The company is based in Dongguan, China. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Dong Mei Su
| Shenyang Pharmaceutical University | Graduate Degree |
| Jilin University | Undergraduate Degree |
Statistik
International
| China | 10 |
| Hong Kong | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Director/Board Member | 9 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| 3SBIO INC. | Health Technology |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Health Technology |
| Private Unternehmen | 7 |
|---|---|
| Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. | |
| Liaoning Sunshine Science & Technology Development Co. Ltd. | |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Health Technology |
Guangdong Sunshine Pharmaceutical Co., Ltd.
Guangdong Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The company is based in Dongguan, China. | Health Technology |
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Health Technology |
Strategic International Group Ltd.
Strategic International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom. | Commercial Services |
- Börse
- Insiders
- Dong Mei Su
- Erfahrung
